Siemens Healthineers Sees Faster Growth in Diagnostics Business

The video features an interview with Bernd Montag, CEO of Siemens Healthineers, discussing the company's profit goals, new diagnostic system Al Tallica, and their strong imaging business. Montag elaborates on the global production strategy, highlighting the flexibility between factories in China and Germany. He identifies emerging markets like Latin America, China, and India as key growth areas. The discussion also covers the potential impact of currency fluctuations and Brexit on the business, emphasizing the company's preparedness for logistical challenges.

What is the name of Siemens Healthineers' new diagnostic system?

• Al Talisman

• Al Tallica

• Al Talon

• Al Tallica

Where has Siemens Healthineers moved some of its production from China?

• USA

• Brazil

• Germany

• India

Which markets are identified as having the biggest growth potential for Siemens Healthineers?

• North America

• Europe

• Australia

• Emerging Markets

How does Siemens Healthineers plan to grow its therapies business?

• Organically and through acquisitions

• By reducing costs

• Through acquisitions only

• By focusing on Europe

Which emerging market currencies have been a concern for Siemens Healthineers?

• China and India

• Argentina and Turkey

• Brazil and Mexico

• South Africa and Russia

What does 'hard Brexit ready' mean for Siemens Healthineers?

• Increasing production

• Reducing workforce

• Ensuring logistics chain stability

• Relocating factories

What is a key strategy for Siemens Healthineers to handle currency risks?

• Focusing on domestic markets

• Hedging

• Increasing prices

• Reducing exports